A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function
NCT00818038
·
clinicaltrials.gov ↗
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG:
BG0002 (natalizumab)
Sponsor
Biogen